What is your goal?
Compounds
A small-molecule inhibitor of the NNMT enzyme (not a peptide). It is explored in research for adipocyte metabolism, energy expenditure, and body-composition effects.
A decoy receptor designed to bind myostatin and activin, blocking their muscle-limiting signaling. It is an experimental research compound explored for increased muscle mass.
The full 39-amino-acid adrenocorticotropic hormone that stimulates adrenal cortisol release. It is studied in endocrine and adrenal-axis research.
A chemically modified nootropic peptide in the Semax research family. It is explored for cognition and neuroprotection studies. (Listed here as a distinct named product; flagged as a vendor-named analogue.)
A targeting peptide designed to act on the vasculature of white adipose tissue. It is an experimental research compound explored for fat-mass reduction.
A copper tripeptide related to GHK-Cu, using an alanine residue. It is explored in research for hair-follicle stimulation and scalp/skin applications.
An AMP-activated protein kinase activator (not a peptide). It is researched as a metabolic and endurance "exercise-mimetic" compound for glucose uptake and fat oxidation.
A prostaglandin E1 compound with vasodilatory activity. It is researched for vascular and erectile-function studies.
A modified fragment derived from the C-terminus of human growth hormone. It is explored in research primarily for lipolysis and fat-metabolism effects without the broader growth-hormone activity.
A small peptide derived from erythropoietin that signals through the tissue-protective receptor without raising red-cell counts. It is studied for neuropathic and tissue-protection research.
A single-chain peptide derived from the hormone relaxin. It is studied for anti-fibrotic and cardiovascular tissue-remodeling research.
A repair-and-skin combination kit; the same family of ingredients as the GLOW blend at different ratios.
A protein that blocks acetylcholine release at the neuromuscular junction. It is included as it appears on the source lists; used cosmetically for the appearance of expression lines. Handled strictly as a regulated research/clinical agent.
A synthetic peptide derived from a protein found in gastric juice. It is widely researched for tissue-repair processes, including tendon, ligament, and gut-lining healing models.
A two-peptide recovery combination commonly studied together for tissue-repair research.
A long-acting amylin-receptor agonist peptide. It is explored for satiety, appetite control, and body-weight reduction, often studied alongside GLP-1 agonists.
An amylin-analogue plus GLP-1-agonist combination studied together for appetite and body-weight research.
A mixture of low-molecular-weight neuropeptides and amino acids. It is studied for neurotrophic support and cognitive-function research.
A CJC-1295 variant with a drug-affinity complex that greatly extends its half-life. It is studied for sustained growth-hormone-releasing effects.
A modified GHRH analogue (no drug-affinity complex) that stimulates pulsatile growth-hormone release. It is researched for recovery, body composition, and growth-hormone-axis support.
A growth-hormone-secretagogue pairing of a GHRH analogue with a ghrelin agonist, commonly researched together.
A potent naturally occurring opioid peptide originally found in amphibian skin. It is an experimental research compound studied for opioid-receptor pharmacology.
A peptide derivative explored for its reported ability to promote synapse formation. It is researched for cognition and memory studies.
A naturally occurring neuropeptide first isolated for its association with sleep. It is researched for sleep regulation and stress-response studies.
A long-acting GLP-1 receptor agonist peptide built as an antibody-Fc fusion. It is studied for glucose metabolism and appetite/weight regulation.
A synthetic tetrapeptide modeled on a pineal-gland bioregulator. It is researched for telomere/longevity studies and circadian-rhythm effects.
A hormone that stimulates red-blood-cell production. It is researched in the context of oxygen-carrying capacity and anemia models.
A protein that binds and neutralizes myostatin and related TGF-beta family members. It is researched for its potential to promote skeletal-muscle growth.
A peptide designed to disrupt the FOXO4-p53 interaction in senescent cells. It is an experimental research compound studied for senolytic ("aging-cell clearing") effects.
GDF-8, also known as myostatin, is a negative regulator of muscle mass. It is supplied as a research protein and studied in muscle-growth and myostatin-pathway research.
The copper-free tripeptide GHK. It is studied for skin-regeneration and collagen-signaling research, and is the base molecule of the GHK-Cu copper complex.
A copper-bound tripeptide naturally found in plasma. It is widely researched for skin remodeling, collagen support, wound-healing models, and hair-follicle effects.
A growth-hormone-releasing peptide that stimulates both GH release and appetite. It is researched for body composition and recovery.
A growth-hormone-releasing peptide with a strong appetite-stimulating effect. It is studied for growth-hormone release, recovery, and body composition.
A three-component blend combining a copper peptide with two repair/anti-inflammatory peptides.
A combination kit pairing a copper peptide with two tissue-repair peptides, commonly explored together for skin and recovery research.
The body's principal intracellular antioxidant tripeptide. It is researched for oxidative-stress balance and is widely explored in skin-brightening contexts.
The natural decapeptide that triggers pituitary release of LH and FSH. It is researched for reproductive-hormone-axis support and signaling studies.
A gonadotropin hormone that mimics luteinizing hormone activity. It is researched for reproductive-axis and gonadal-function studies.
A potent growth-hormone-releasing peptide. It is researched for growth-hormone release and has additional research interest in cardiac tissue effects.
Recombinant 191-amino-acid human growth hormone. It is studied for its broad effects on muscle and connective tissue, body composition, and recovery.
The 176-191 amino-acid fragment of human growth hormone. It is studied for its reported fat-mobilizing properties and is researched specifically for lipolysis.
A vendor-formulated blend marketed for hair, skin, and nail support. Its composition is not a single defined peptide; catalogued as a blend.
A gonadotropin preparation containing FSH and LH activity. It is studied in reproductive-hormone and fertility research.
A small peptide encoded in mitochondrial DNA. It is studied for cytoprotection, metabolic, and neuroprotective research interests.
A naturally occurring hydrating polysaccharide. It is widely used and studied for skin hydration and tissue lubrication; included here as it appears on the source lists.
A truncated, locally-acting variant of IGF-1. It is studied for localized muscle-cell growth and hypertrophy research.
A long-acting analogue of insulin-like growth factor 1 with extended half-life. It is researched for muscle-cell growth, protein synthesis, and tissue recovery.
The peptide hormone central to blood-glucose regulation. Included as it appears on the source lists; studied in metabolism and glucose-handling research.
A selective ghrelin-receptor agonist that prompts growth-hormone release with minimal effect on other hormones. It is researched for recovery, body composition, and sleep quality.
A peptide that acts upstream of GnRH to regulate reproductive hormone release. It is researched for reproductive-axis signaling and has interest in libido research.
A four-component repair blend adding KPV to the GLOW-family ingredients.
A tripeptide fragment of alpha-MSH (lysine-proline-valine). It is researched for anti-inflammatory signaling, with interest in gut-lining and skin models.
L-carnitine and "lipotropic" MIC-style blends (often combined with B-vitamins) support fatty-acid transport into mitochondria. They are explored in research contexts for fat metabolism and exercise energy use.
A branded cosmetic lipolytic solution marketed for localized fat reduction. Its exact composition is not a single defined peptide; it is included here as a blend with that caveat.
An earlier-generation daily GLP-1 receptor agonist peptide. It is researched for appetite regulation, glucose metabolism, and body-weight effects.
A naturally occurring host-defense peptide of the cathelicidin family. It is researched for antimicrobial activity, immune modulation, and wound-healing models.
A cosmetic peptide that signals skin cells to support collagen and matrix proteins. It is researched for skin-firmness and fine-line appearance.
A dual GLP-1 and glucagon receptor agonist peptide. It is explored in research for body-weight reduction and metabolic regulation.
A melanocortin-receptor agonist peptide that stimulates melanin production. It is researched for skin-pigmentation ("tanning") studies.
A non-selective melanocortin-receptor agonist peptide. It is researched for skin-pigmentation effects and also has research interest in libido.
The body's circadian-rhythm hormone produced by the pineal gland. It is widely studied for sleep onset and circadian-rhythm research.
A splice variant of IGF-1 expressed in response to mechanical muscle loading. It is researched for muscle-fiber repair and growth after exercise stress.
A mitochondrial-derived peptide involved in metabolic regulation. It is researched as an "exercise-mimetic" for insulin sensitivity, metabolism, and endurance.
A chemically stabilized form of Epitalon with terminal modifications for greater resilience. It is explored for the same longevity and circadian research interests as Epitalon.
A chemically stabilized form of Selank with terminal modifications. It is explored for the same anxiolytic and cognitive research interests as Selank.
An essential cellular coenzyme central to energy metabolism and DNA repair. It is researched for cellular-energy and longevity studies.
A naturally occurring nine-amino-acid hormone involved in social bonding and reproduction. It is studied for mood, social-behavior, and bonding research.
A small peptidomimetic derived from a region of ciliary neurotrophic factor. It is studied for neurogenesis and cognitive-support research.
A peptide derived from spadin that blocks the TREK-1 potassium channel. It is researched for mood-related and antidepressant-mechanism studies.
A PEGylated form of MGF with extended stability and half-life. It is explored for the same muscle-repair and growth research interests as MGF.
A family of short (2-4 amino-acid) synthetic peptides each associated in research with a specific tissue or organ system. They are studied for tissue-specific regulatory and longevity research; each name above maps to its target tissue.
A short peptide bioregulator associated with brain and pineal tissue. It is researched for cognitive-function and neuroprotective studies. (Also a member of the bioregulator family above.)
A peptide combining a p53-derived domain with a membrane-penetrating sequence. It is an experimental research compound studied for selective effects on cancer-cell membranes.
A melanocortin-receptor agonist peptide derived from Melanotan II. It is researched specifically for sexual-desire and arousal studies.
A triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. It is studied for substantial weight reduction and broad metabolic effects, with the glucagon arm of interest for energy expenditure research.
A triple-agonist plus amylin-analogue combination explored for metabolic and weight research.
A synthetic peptide derived from the immunopeptide tuftsin. It is researched for anxiety-related behavior, stress resilience, and cognitive effects.
A long-acting GLP-1 receptor agonist peptide. It is commonly explored in research for appetite regulation, body-weight reduction, and glucose-metabolism effects.
A synthetic peptide derived from a fragment of ACTH. It is researched as a nootropic for focus, memory, and neuroprotection studies.
A nootropic peptide paired with an anxiolytic peptide, commonly studied together for cognition and mood research.
A truncated GHRH analogue that stimulates endogenous growth-hormone release. It is studied for growth-hormone-axis support, recovery, and sleep.
A synthetic agonist of estrogen-related receptors, sometimes described as an "exercise-mimetic" research compound. It is studied for oxidative metabolism, endurance capacity, and fat oxidation.
An eight-amino-acid cosmetic peptide that modulates neurotransmitter release at the muscle. It is studied topically for the appearance of expression lines.
A peptide that targets the inner mitochondrial membrane and stabilizes cardiolipin. It is studied for mitochondrial-function and cellular-energy research.
A dual GLP-1 / glucagon receptor agonist peptide. It is researched for weight reduction and for liver-fat and metabolic-health endpoints.
A peptide related to thymosin beta-4, an actin-regulating protein. It is studied for cell migration, tissue repair, and recovery research.
A recombinant fragment of parathyroid hormone. It is researched for bone-formation and bone-density studies.
A stabilized GHRH analogue that stimulates endogenous growth-hormone release. It is researched notably for reduction of visceral adipose tissue.
A peptide bioregulator derived from the thymus. It is studied for immune-system modulation and aging research.
A 28-amino-acid thymic peptide that modulates immune-cell activity. It is researched for immune-system support and inflammatory-balance studies.
A dual-incretin peptide acting on both GLP-1 and GIP receptors. It is widely researched for appetite suppression, weight reduction, and metabolic outcomes.
A long-acting GnRH agonist peptide. It is studied for its effects on the reproductive-hormone axis through sustained receptor stimulation.
A naturally occurring signaling peptide active in the gut, lungs, and nervous system. It is researched for immune modulation and inflammatory-balance studies.
An essential vitamin central to nerve function and red-cell formation. Included as it appears on the source lists; explored for energy and neurological support.